Cargando…

Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria

OBJECTIVES: Remission is a widely accepted goal for treatment of rheumatoid arthritis (RA) but has to be sustained to arrest joint damage and disability. However, appropriate criteria for the assessment of sustained remission in long-term studies are not established. Therefore, we have compared the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svensson, Björn, Andersson, Maria L E, Bala, Sidona-Valentina, Forslind, Kristina, Hafström, Ingiäld
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Rheumatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773654/ https://www.ncbi.nlm.nih.gov/pubmed/24022393 http://dx.doi.org/10.1136/bmjopen-2013-003554

Ejemplares similares

Reported disability in relation to observed activity limitation, grip strength and physical function in women and men with rheumatoid arthritis
por: Bala, Sidona-Valentina, et al.
Publicado: (2021)

Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial
por: Ajeganova, Sofia, et al.
Publicado: (2014)

A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance
por: Hafström, Ingiäld, et al.
Publicado: (2019)

Misdiagnosis of Rheumatoid Arthritis in a Long-Term Cohort of Early Arthritis Based on the ACR-1987 Classification Criteria
por: Leu Agelii, Monica, et al.
Publicado: (2022)

Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years
por: Ajeganova, Sofia, et al.
Publicado: (2023)

Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study
por: Hafström, Ingiäld, et al.
Publicado: (2014)

Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort
por: Hafström, Ingiäld, et al.
Publicado: (2019)

Does digital X-ray radiogrammetry have a role in identifying patients at increased risk for joint destruction in early rheumatoid arthritis?
por: Forslind, Kristina, et al.
Publicado: (2012)

Erosion-free rheumatoid arthritis: clinical and conceptional implications—a BARFOT study
por: Svensson, Björn, et al.
Publicado: (2022)

Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis – A BARFOT Study
por: Andersson, Maria L.E, et al.
Publicado: (2015)

Influence of Age and Sex on Disease Course and Treatment in Rheumatoid Arthritis
por: Nilsson, Jenny, et al.
Publicado: (2021)

Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study
por: Svensson, Björn, et al.
Publicado: (2014)

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis
por: Andersson, Maria L E, et al.
Publicado: (2013)

Serum Reactive Oxygen Metabolites as a Predictor of Clinical Disease Activity Index, Simplified Disease Activity Index, and Boolean Remissions in Rheumatoid Arthritis Patients Treated With Biologic Agents
por: Nakajima, Arata, et al.
Publicado: (2021)

Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms
por: Frostegård, Johan, et al.
Publicado: (2021)

Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission
por: Ben Abdelghani, Kawther, et al.
Publicado: (2022)

Utility of the new rheumatoid arthritis 2010 ACR/EULAR classification criteria in routine clinical care
por: Kennish, Lauren, et al.
Publicado: (2012)

Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort
por: Vallejo-Yagüe, Enriqueta, et al.
Publicado: (2022)

TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA)
por: Kleinrensink, Nienke J, et al.
Publicado: (2022)

Patient’s perspective of sustained remission in rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2017)

Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Biomarkers in Rheumatoid Arthritis
por: Shapiro, Samantha C
Publicado: (2021)

Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA)
por: Emery, Paul, et al.
Publicado: (2018)

Long-term outcomes after coronary artery bypass surgery in patients with rheumatoid arthritis
por: Malmberg, Markus, et al.
Publicado: (2021)

Reasons to stop drinking alcohol among patients with rheumatoid arthritis in Sweden: a mixed-methods study
por: Larsson, Ingrid, et al.
Publicado: (2018)

ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial
por: Dirikgil, Ebru, et al.
Publicado: (2022)

Remission in Rheumatoid Arthritis
por: Shammas, Rania M., et al.
Publicado: (2010)

Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal
por: Leong, Jing Yao, et al.
Publicado: (2019)

Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria
por: Smolen, Josef S., et al.
Publicado: (2017)

Sustained rheumatoid arthritis remission is uncommon in clinical practice
por: Prince, Femke HM, et al.
Publicado: (2012)

Defining and characterizing sustained remission in patients with rheumatoid arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2017)

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Sustained Remission in Rheumatoid Arthritis: Time to Withdraw Treatment?
por: Sungur, Can M.
Publicado: (2021)

Ultrasound remission in patients with rheumatoid arthritis in clinical remission
por: Fakhfakh, Rym, et al.
Publicado: (2021)

Biological tapering and sonographic flare in rheumatoid arthritis
por: Ko, Chi-Hua, et al.
Publicado: (2018)

Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
por: Kimura, Noriko, et al.
Publicado: (2019)

Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
por: Woerner, A, et al.
Publicado: (2015)

Role of Diet in Influencing Rheumatoid Arthritis Disease Activity
por: Badsha, Humeira
Publicado: (2018)

Evaluating the Use of Hydroxychloroquine in Treating Patients With Rheumatoid Arthritis
por: Nazir, Armaan M, et al.
Publicado: (2021)

Prevalence and Severity of Temporomandibular Disorders in Rheumatoid Arthritis Patients
por: Mustafa, Mohammad A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jngm73u8cdn6opeskb0a7m3k5l